Novavax (NVAX) Change in Inventory (2021 - 2026)

Novavax's Change in Inventory history runs 6 years deep, the most recent figure standing at $226000.0 for Q1 2026.

• On a quarterly basis, Change in Inventory rose 109.52% year-over-year to $226000.0 in Q1 2026; TTM through Mar 2026 was $5.8 million, a 281.76% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 125.09% from the prior year.
• Change in Inventory grew to $226000.0 in Q1 2026 per NVAX's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $304.2 million in Q2 2022 and bottomed at -$16.8 million in Q1 2024.
• The 5-year median for Change in Inventory is $3.8 million (2025), against an average of $31.9 million.
• Across the five-year window, Change in Inventory soared 478.62% in 2022 and plunged 1236.51% in 2025, its largest moves.
• Year by year, Change in Inventory stood at $51.3 million in 2022, then sank by 115.75% to -$8.1 million in 2023, then surged by 102.34% to $189000.0 in 2024, then sank by 1236.51% to -$2.1 million in 2025, then jumped by 110.52% to $226000.0 in 2026.
• Per Business Quant, the three latest NVAX Change in Inventory figures stand at $226000.0 (Q1 2026), -$2.1 million (Q4 2025), and $3.8 million (Q3 2025).